How to evaluate the lung functions of DMD patients and the trend of conversion Source: Eur Respir J 2007; 30: Suppl. 51, 183s Year: 2007
Interleukine-17A implicated in survival outcome of patients with late stage lung adenocarcinoma Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018
Features affecting stages of patients with lung cancer at diagnosis Source: Eur Respir J 2005; 26: Suppl. 49, 536s Year: 2005
Cyst-related primary lung malignancies: an important and relatively unknown imaging appearance of (early) lung cancer Source: Eur Respir Rev, 27 (150) 180079; 10.1183/16000617.0079-2018 Year: 2018
Surgery for non small cell lung cancer (NSCLC) and functional limits: is there a possible beneficial role of preoperative pulmonary rehabilitation? Source: Eur Respir J 2004; 24: Suppl. 48, 522s Year: 2004
Quantification of telomerase activity is important in predicting prognosis of patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 482s Year: 2005
Reflex testing is crucial for treatment decisions in advanced non small cell lung cancer (NSCLC) Source: International Congress 2017 – Chinese Programme 2017 Year: 2017
The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006
The influence of secondary infectious process on non-small cell lung cancer (NSCLC) patients survival Source: Eur Respir J 2007; 30: Suppl. 51, 280s Year: 2007
First hospitalization in lung cancer patients – is timing important? Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021
Does the lung function affect the survival time in patients with resected non-small cell lung cancer? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007
Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017
The role of tumor size in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006
Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020
A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010
Characteristics and prognostic relevance of p 53 gene mutations in Polish non small cell lung cancer (NSCLC) patients Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
Which functional alteration is mainly the cause in determining dyspnoeain COPD patients? Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004
Stage I lung cancer patients with or without symptoms – are the patients any different? Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020
Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004